Cargando…

Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization

BACKGROUND: Evidence from animal studies suggests that exposure to organophosphate flame retardants (PFRs) can disrupt endocrine function and impair embryo development. However, no epidemiologic studies have been conducted to evaluate effects on fertility and pregnancy outcomes. OBJECTIVES: We evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Carignan, Courtney C., Mínguez-Alarcón, Lidia, Butt, Craig M., Williams, Paige L., Meeker, John D., Stapleton, Heather M., Toth, Thomas L., Ford, Jennifer B., Hauser, Russ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783651/
https://www.ncbi.nlm.nih.gov/pubmed/28858831
http://dx.doi.org/10.1289/EHP1021
_version_ 1783295315546210304
author Carignan, Courtney C.
Mínguez-Alarcón, Lidia
Butt, Craig M.
Williams, Paige L.
Meeker, John D.
Stapleton, Heather M.
Toth, Thomas L.
Ford, Jennifer B.
Hauser, Russ
author_facet Carignan, Courtney C.
Mínguez-Alarcón, Lidia
Butt, Craig M.
Williams, Paige L.
Meeker, John D.
Stapleton, Heather M.
Toth, Thomas L.
Ford, Jennifer B.
Hauser, Russ
author_sort Carignan, Courtney C.
collection PubMed
description BACKGROUND: Evidence from animal studies suggests that exposure to organophosphate flame retardants (PFRs) can disrupt endocrine function and impair embryo development. However, no epidemiologic studies have been conducted to evaluate effects on fertility and pregnancy outcomes. OBJECTIVES: We evaluated associations between urinary concentrations of PFR metabolites and outcomes of in vitro fertilization (IVF) treatment among couples recruited from an academic fertility clinic. METHODS: This analysis included 211 women enrolled in the Environment And Reproductive Health (EARTH) prospective cohort study (2005–2015) who provided one or two urine samples per IVF cycle. We measured five urinary PFR metabolites [bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), diphenyl phosphate (DPHP), isopropylphenyl phenyl phosphate (ip-PPP), tert-butylphenyl phenyl phosphate (tb-PPP), and bis(1-chloro-2-propyl) phosphate (BCIPP)] using negative electrospray ionization liquid chromatography tandem mass spectrometry (LC-MS/MS). Molar concentrations of the urinary PFR metabolites were summed. We used multivariable generalized linear mixed models to evaluate the association of the PFR metabolites with IVF outcomes, accounting for multiple IVF cycles per woman. RESULTS: Detection frequencies were high for BDCIPP (87%), DPHP (94%), and ip-PPP (80%), but low for tb-PPP (14%) and BCIPP (0%). We observed decreased success for several IVF outcomes across increasing quartiles of both summed and individual PFR metabolites (DPHP and ip-PPP) in our adjusted multivariable models. Significant declines in adjusted means from the lowest to highest quartile of [Formula: see text] were observed for the proportion of cycles resulting in successful fertilization (10% decrease), implantation (31%), clinical pregnancy (41%), and live birth (38%). CONCLUSIONS: Using IVF to investigate human reproduction and pregnancy outcomes, we found that concentrations of some urinary PFR metabolites were negatively associated with proportions of successful fertilization, implantation, clinical pregnancy, and live birth. https://doi.org/10.1289/EHP1021
format Online
Article
Text
id pubmed-5783651
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-57836512018-03-02 Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization Carignan, Courtney C. Mínguez-Alarcón, Lidia Butt, Craig M. Williams, Paige L. Meeker, John D. Stapleton, Heather M. Toth, Thomas L. Ford, Jennifer B. Hauser, Russ Environ Health Perspect Research BACKGROUND: Evidence from animal studies suggests that exposure to organophosphate flame retardants (PFRs) can disrupt endocrine function and impair embryo development. However, no epidemiologic studies have been conducted to evaluate effects on fertility and pregnancy outcomes. OBJECTIVES: We evaluated associations between urinary concentrations of PFR metabolites and outcomes of in vitro fertilization (IVF) treatment among couples recruited from an academic fertility clinic. METHODS: This analysis included 211 women enrolled in the Environment And Reproductive Health (EARTH) prospective cohort study (2005–2015) who provided one or two urine samples per IVF cycle. We measured five urinary PFR metabolites [bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), diphenyl phosphate (DPHP), isopropylphenyl phenyl phosphate (ip-PPP), tert-butylphenyl phenyl phosphate (tb-PPP), and bis(1-chloro-2-propyl) phosphate (BCIPP)] using negative electrospray ionization liquid chromatography tandem mass spectrometry (LC-MS/MS). Molar concentrations of the urinary PFR metabolites were summed. We used multivariable generalized linear mixed models to evaluate the association of the PFR metabolites with IVF outcomes, accounting for multiple IVF cycles per woman. RESULTS: Detection frequencies were high for BDCIPP (87%), DPHP (94%), and ip-PPP (80%), but low for tb-PPP (14%) and BCIPP (0%). We observed decreased success for several IVF outcomes across increasing quartiles of both summed and individual PFR metabolites (DPHP and ip-PPP) in our adjusted multivariable models. Significant declines in adjusted means from the lowest to highest quartile of [Formula: see text] were observed for the proportion of cycles resulting in successful fertilization (10% decrease), implantation (31%), clinical pregnancy (41%), and live birth (38%). CONCLUSIONS: Using IVF to investigate human reproduction and pregnancy outcomes, we found that concentrations of some urinary PFR metabolites were negatively associated with proportions of successful fertilization, implantation, clinical pregnancy, and live birth. https://doi.org/10.1289/EHP1021 Environmental Health Perspectives 2017-08-25 /pmc/articles/PMC5783651/ /pubmed/28858831 http://dx.doi.org/10.1289/EHP1021 Text en EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Research
Carignan, Courtney C.
Mínguez-Alarcón, Lidia
Butt, Craig M.
Williams, Paige L.
Meeker, John D.
Stapleton, Heather M.
Toth, Thomas L.
Ford, Jennifer B.
Hauser, Russ
Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization
title Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization
title_full Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization
title_fullStr Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization
title_full_unstemmed Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization
title_short Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization
title_sort urinary concentrations of organophosphate flame retardant metabolites and pregnancy outcomes among women undergoing in vitro fertilization
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783651/
https://www.ncbi.nlm.nih.gov/pubmed/28858831
http://dx.doi.org/10.1289/EHP1021
work_keys_str_mv AT carignancourtneyc urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT minguezalarconlidia urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT buttcraigm urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT williamspaigel urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT meekerjohnd urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT stapletonheatherm urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT toththomasl urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT fordjenniferb urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT hauserruss urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization
AT urinaryconcentrationsoforganophosphateflameretardantmetabolitesandpregnancyoutcomesamongwomenundergoinginvitrofertilization